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A B S T R A C T
Introduction. Coping with cancer, its treatment and recovery are dyadic processes within a relationship. Sexual
dysfunctions and problems of penile cancer may add to the demands of coping.
Aim. The prospective study aimed to describe the dyadic aspects of sexual well-being and life satisfaction before and
1 year after organ-sparing laser treatment of penile carcinoma.
Methods. A consecutive series of 29 patients with penile carcinoma suitable for laser treatment were included
together with their partners, median age 60 (37–73) years and 57 (30–72) years, respectively. Median length of
relationship was 29 years (1–54 years). The participants completed structured interviews before treatment, at 6
months’ and 12 months’ follow-up. The interview addressed sexual activities, sexual functions, verbal (sexual)
communication, and life satisfaction.
Main Outcome Measures. Three well-validated instruments were included: Hospital Anxiety and Depression Scale,
International Index of Erectile Function-5, and Life Satisfaction checklist, LiSat-11. The interviews contained the
same questions for patients and partners at all three measuring points.
Results. There was a high level of within-couple agreement on sexual activities, sexual function, and life satisfaction
before and after organ-sparring treatment. No signiﬁcant differences between interview data at 6 and 12 months’
follow-up occurred. Before treatment, sexual dysfunctions were common among men, especially decreased sexual
interest and dyspareunia. At follow-up, increased sexual function was found, with the exception of erectile function
and women’s orgasm. A rather high proportion was being unsatisfactory sexually inactive. Few had an ongoing verbal
(sexual) mutual communication. Couples with an active sexual life at follow-up showed coherence in high satisfaction
with life as a whole.
Conclusion. A high level of within-couple agreement concerning sexuality and life satisfaction points to the necessity
of including an adequate sexological case history, counseling, and treatment for this group of patients and their
partners. Skeppner E and Fugl-Meyer K. Dyadic aspects of sexual well-being in men with laser-treated
penile carcinoma. Sex Med 2015;3:67–75.
KeyWords. Penile Carcinoma; Laser Treatment; Prospective; Organ-Sparing; Sexual Function; Sexual Dysfunction;
Sexual Satisfaction; Life Satisfaction
Introduction
Penile carcinoma is a relatively rare disease inthe Western population with variations within
several European regions, ranging from 0.5 to 1.6
per 100,000 males; the incidence is slightly
increasing. In the non-Western world, the inci-
dence is much higher and can reach as much as
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10% of all malignant diseases in men [1]. Penile
carcinoma mostly affects the elderly population
[2].
Long patients’ delay in seeking treatment, as
well as varied treatment options with impact on
sexual life, is common [3]. However, research
focusing this group of patients is quite rare, prob-
ably due to small, heterogeneous samples and a
mixture of treatment opportunities making com-
parisons difﬁcult.
Worldwide, only a few studies have focused on
the psychological and social impact of penile
cancer and its different treatment modalities. The
psychosocial impact of penile cancer and, not the
least, the symbolic nature of genital cancer, with
vulnerability in terms of the man’s sense of mas-
culinity, may lead to sexual dysfunctions, adding to
the demands of coping. In a small qualitative study
among men with penile cancer treated with partial
or total penile amputation, the impact on quality
of life and sexuality was studied by Bullen et al. [4].
The authors found that penile amputation alters
the sense of masculinity, but psycho-sexual adap-
tation was feasible for men in strong and support-
ive relationships. Evidence for maintaining overall
sexual well-being with organ-sparing treatment in
contrast to partial penile amputation has, though,
been found [5–11].
We have previously found that men, treated
with combined laser treatment, to a large extent
resumed their sexual activities after treatment,
despite distressing decreased erectile function and
low sexual interest in a ﬁfth of the patients [12].
However, in that retrospective study, there was a
lack of a dynamic partner perspective. If the treat-
ment causes sexual dysfunctions, it will, most
likely, affect the partner. Furthermore, partners’
sexual dysfunctions can affect the patients’ sexual-
ity [13].
The aim of this prospective study was to
describe dyadic aspects of sexual well-being and
life satisfaction before and 1 year after organ-
sparing laser treatment of penile carcinoma. The
hypothesis was that couples with congruent expe-
riences of sexual activities and sexual functions
who were active in communication about sexuality
are able to cope satisfactorily with partner rela-
tionship, sexual life, and life as a whole.
The study is one in a series of reports on men
who have had organ-sparing laser treatment for
penile carcinoma. We have previously described
their demographic data, symptoms, treatment-
seeking behavior, comorbidities, sexual functions/
dysfunctions, sexual activities, and satisfaction.
The age span ranged from 37 years up to 90 years,
and the partners were not included [3,12,14].
Methods
In the present prospective observational study
addressing sexuality, and life satisfaction, couples
were approached at three measuring points: imme-
diately prior to treatment for penile carcinoma,
and after 6 and 12 months. The deﬁnition of
partner was characterized as having a stable
partner relationship (hetero or homosexual) but
not necessarily cohabiting.
The researchers used face-to-face semi-
structured interviews. One and the same inter-
viewer (E.S., an experienced medical social worker
not involved in the patients’ clinical care) pre-
sented the items orally. The interview lean on an
meticulous sexological case history (including 50
questions). Sexual dysfunctions (see Table 2) were
deﬁned as follows: low desire/decreased sexual
interest (men and women), absent or diminished
feelings of sexual desire or interest, respectively,
with absent feelings of sexual thoughts or fantasies;
erectile dysfunction, consistent or recurrent
inability to attain and/or maintain penile erection
sufﬁcient for sexual activity; premature ejacula-
tion, ejaculation occurring sooner than desired
(within 2 minutes; before or shortly after penetra-
tion over which the man has minimal or no
control); retarded/anejaculation, undue delay or
absence of ejaculation during sexual activity;
dyspareunia (men and women), persistent or
recurrent genital pain during sexual activity;
female lubrication dysfunction, absence of or
marked diminished feelings of sexual arousal
and/or complains of absent or impaired genital
sexual arousal; and orgasmic dysfunction (women),
lack of orgasm or marked delay of orgasm from
any kind of sexual stimulation (all these concern-
ing manifest sexual dysfunctions, i.e., occurring
always, nearly always, rather often). This was fol-
lowed by three validated self-reporting question-
naires (see below) completed by the participants.
The sessions were individual for patients and their
partners. Each interview took approximately 1
hour.
Main Outcome Measures
The structured interviews had almost identical
questions for patients and partners, at all three
measuring points. The questions covered de-
mographic data, comorbidity, sexual function/
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dysfunction, sexual activities, and occurrence of
verbal communication about sexuality and life sat-
isfaction. Moreover, three self-reporting, well-
validated instruments were included. Concerning
life satisfaction (LiSat-11), an ad hoc comparator
population of 935 men and 809 women, aged 34 to
74 years, were extracted from a nationally represen-
tative study of sexual life and life satisfaction in
Sweden [15].
Self-Report Instruments
LiSat-11
LiSat-11 is a generic instrument with 11 state-
ments encompassing perceived actual satisfaction
with life as a whole as well as satisfaction with 10
speciﬁc domains of life. Along a six-graded scale,
possible answers range from very dissatisﬁed to
very satisﬁed. Responses can validly be dichoto-
mized into satisﬁed (very satisﬁed and satisﬁed) or
not satisﬁed (rather satisﬁed, rather dissatisﬁed,
dissatisﬁed, and very dissatisﬁed) [13]. Construct
analysis has shown that each domain is incorpo-
rated in one of four factors: health, closeness,
leisure, and provision.
Anxiety and Depression:The Hospital Anxiety
and Depression Scale (HADS)
The well-validated Hospital Anxiety and Depres-
sion Scale (HADS) consists of 14 questions [16].
Seven items measure occurrence of anxiety, and
seven measure depression. Each item has a four-
graded scale for answers with scores (0–3) con-
structed for aggregation of each of the two
subscales. Cutoff scores for anxiety and depres-
sion, respectively, have been identiﬁed as ≥11 [17].
Erectile Function:The International Index of
Erectile Function (IIEF-5)
For assessing erectile function, the universally
used IIEF-5 was included [18]. The aggregated
score ranges from 1 to 25; the cutoff score of ≥21
signiﬁes the border between normal and subnor-
mal erectile function.
Statistics
The data were analyzed with the use of spss
version 17 (SPSS inc, Chicago, IL, USA).
Numbers of subjects are generally given in the
results owing to the small sample size.
We assessed the level of agreement between the
partners’ reports of sexual activities, dysfunction,
and satisfaction using Cohen’s kappa for categori-
cal variables, determining whether the level of
agreement was signiﬁcantly higher than the level
expected to occur by chance (where values >0.60
represented substantial to strong agreement).
The nonparametric sign test was used to test
differences in medians in the distribution over
time comparing satisfaction with sexual life at
baseline and after 12 months. The chosen level of
signiﬁcance was α of 0.05.
Ethics
The study was approved by the Regional Ethics
Review Board, Uppsala Sweden (2005:112).
Informed consent was approved/given by patients
and their partners.
Results
As no signiﬁcant differences were found between
the interview data at 6 and 12 months, results are
given at baseline and at 12 months of follow-up.
Study Participants
Included were all patients younger than 75 years
who were referred to Department of Urology,
University Hospital Örebro, Sweden, with penile
carcinoma suitable for laser treatment and not pre-
viously treated with combined laser. During the
period May 2005 to April 2009, 67 patients ful-
ﬁlled the criteria and were invited to participate in
the prospective study. Eight men declined partici-
pation. Furthermore, nine participated in the
baseline interview but were later judged to have
tumor stages too advanced to be suitable for
organ-sparing therapy. Of the remaining 50
patients, 41 (82%) had a stable relationship. One
couple lived in a homosexual relationship.
Thirty-four partners of these 41 eligible
patients agreed to participate and were inter-
viewed at baseline; 31 were interviewed at 6
months’ follow-up and 29 at 12 months’ follow-
up. Thus, the response rate was 83% at baseline.
Three partners declined to participate without
explanation at the 6-month follow-up, and at 12
months, a further two were lost due to separation
and death, leaving 29 couples fulﬁlling all three
interviews. The response rate was 71% at the
12-month follow-up.
Patients with partners unwilling to participate
in the study were found to be signiﬁcantly older
but did not differ concerning tumor stage, sexual
function, or sexual activities. Partners who were
initially included but dropped out at the second or
third interview did not differ (signiﬁcantly) in any
of the investigated variables.
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Sociodemographics
Patients’ median age was 60 years (range 37–73),
and partners’ 57 years (range 30–72). Eight
couples were retired, and all others were vocation-
ally active. The median duration of the relation-
ships was 29 years (range 1–54 years).
Health
The majority (n = 12) had tumor stage pT1, and
14 had tumor grade G2. Two patients had a total
penectomy between 6 and 12 months after ﬁrst
treatment.
There was a high level of comorbidity at base-
line, with 16/29 (55%) of the patients reporting
concomitant and diagnosed illnesses, along with
13/29 (45%) of the partners (Table 1). According
to the HADS [16], none were depressed at any of
the three measuring points. Anxiety was, on the
other hand, present among ﬁve partners at base-
line but not at follow-up, while two patients were
found with anxiety 12 months after treatment.
Couples at Diagnosis and 1 Year after
Laser Treatment
Eight couples had not been sexually active, with
penetrative intercourse, for several years before
the laser treatment; the reasons given were symp-
toms of penile carcinoma, concomitant illness (see
Table 1), and own or partner’s decreased sexual
interest. Nor had these couples resumed sexual
activities at 12 months’ follow-up. For the 21 sexu-
ally active couples, activities showed minor and
statistically nonsigniﬁcant changes from baseline
to follow-up 1 year later.
At the 12-month follow-up, four couples had
ceased having penetrative intercourse but were
sexually active in other ways. These couples
reported that this withdrawal was caused by the
penile carcinoma and/or its treatment. The four
patients were found with tumor stages T1–T2.
Two of these men had had total penectomy due to
relapse (tumors staged pT2, G2, and G3 respec-
tively). Notably, both had been able to resume
penetrative intercourse during the ﬁrst months
after laser treatment and up until the time of
relapse. The couples showed high within-couple
agreement (interpartner reliability) with respect to
having penetrative intercourse (Table 2). Time
since last sexual activity was estimated by most of
the couples to be within the last month (11/21
pretreatment and 16/19 post-treatment).
Sexual Function and Dysfunction
Of the 21 sexually active, with penetrative inter-
course, the most common sexual dysfunction
among patients was manifest dyspareunia (see
Table 2). As many as 10 out of this 21 suffered
from genital sexual pain. However, at 12 months’
follow-up, this dysfunction remained for two men.
Furthermore, at 12 months, almost half of the
patients (15/29) experienced decreased sensibility
of the glans penis; all but two reported these
somatic sensations as negative.
Concerning other sexual dysfunctions, only
manifest decreased sexual interest occurred more
frequently (13/29 before and 10/29 after treat-
ment) than dyspareunia. Sexual desire dysfunction
had a much lower prevalence, as did manifest pre-
mature ejaculation. Manifest retarded ejaculation/
anejaculation occurred for six of the 21 before and
four after treatment. For the sexually active, mani-
fest erectile dysfunction occurred in two patients
prior to treatment and in three at follow-up.
The IIEF score was registered as “normal” with
a score ≥22 in 14 patients before and in 10 patients
at 1 year after treatment. Before being diagnosed
with penile carcinoma, two men had received
PDE5 inhibitors, and at follow-up, a further four
patients used this pharmacological treatment with
success. The prevalence of sexual dysfunction had
Table 1 Diagnosed comorbidity, including anxiety and depression (HADS), in 29 patients treated for penile carcinoma
and their partners
Patients at
baseline
Patients at
12 months
Partners at
baseline
Partners at
12 months
Diagnosed comorbidity* 16 (55%) 17 59%) 8 (28%) 13 (45%)
Hypertension 10 11 6 8
Diabetes mellitus 4 4 0 0
Cardiovascular disease 8 8 0 0
Chronic pain 3 3 5 5
Anxiety (HADS)† 0 2 5 0
Depression (HADS)† 0 0 0 0
*More than one diagnosis could be specified by individuals
†One partner declined self-assessment at baseline
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decreased for all male dysfunctions, except for
erectile dysfunction, at the 12-month follow-up.
Among the partners, the most common sexual
dysfunction was low sexual desire (eight partners at
baseline and nine a year later), followed by
decreased vaginal lubrication (ﬁve and two women,
respectively). Orgasmic dysfunction was reported
by one woman at baseline and a further three at
follow-up. No partner reported dyspareunia or
vaginismus.
There was a within-couple–agreement con-
cerning erectile dysfunction, retarded ejaculation
(at baseline) and decreased vaginal lubrication
(Table 2).
At the time prior to treatment, 12/29 (41%) of
the couples reported an active ongoing verbal
communication about (their) sexuality; 1 year
later, one couple had ceased such communica-
tion. Seven patients and ﬁve partners had raised
questions on sexual issues with the health care
personnel.
Life Satisfaction
At baseline, and after 12 months, similar propor-
tions of patients and partners were satisﬁed/very
satisﬁed with life as a whole, at par with (or more
than) the comparators (Table 3). Two items, satis-
faction with somatic health and with sexual life,
Table 2 Prevalence of sexual activity, sexual dysfunctions, and satisfaction in patients treated for penile carcinoma and
their partners, at baseline and at 12-month follow-up
Baseline 12 months
Patients Partners
Within-couple
agreement (%) Patients Partners
Within-couple
agreement (%)
Sexual activity
Penetrative intercourse 21/29 21/29 29/29* (100) 17/29 17/29 29/29* (100)
Sexual dysfunction, manifest
Low desire (m/p) 3/29 8/29 20/29 (69) 2/29 9/29 20/29 (69)
Decreased interest (m/p) 13/29 10/29 21/29 (72) 10/29 9/29 18/29 (62)
Erectile dysfunction (m) 2/21 2/21 21/21* (100) 3/17 2/17 16/17* (94)
Premature ejaculation (m) 1/21 1/21 19/21 (90) 0 0 17/17 (100)
Retarded/anejaculation (m) 6/21 5/21 20/21* (95) 4/17 5/17 12/17 (71)
Dyspareunia (m/p) 10/21 0 2/17 0
Female lubrication dysfunction (w) 2/21 5/21 16/21 (76) 2/17 2/17 17/17* (100)
Female orgasmic dysfunction (w) 3/21 1/21 17/21 (81) 1/17 4/17 14/17 (82)
Satisfaction
Sexual satisfaction 17/28 13/27 20/26 (77) 9/28 12/24 17/24 (71)
Partner satisfaction 24/29 25/28 23/28 (82) 23/29 24/29 24/29 (83)
Life satisfaction 23/29 24/28 20/28 (71) 22/29 24/29 19/29 (66)
Within-couple agreement in answers is given *Kappa value >0.60
m = men; p = partner; w = women
Table 3 Satisfaction with life as a whole and10 domains of life in patients and their partners, before the treatment and
1 year after
Satisfied with
Patients at
baseline (%)
Patients after
12 months (%)
Partners at
baseline (%)
Partners after
12 months (%)
Swedish men
34–74 years
n: 935 (%)
Swedish women
34–74 years
n: 809 (%)
Life as a whole 23/29 (79) 22/29 (76) 24/28 (86) 24/29 (83) 72 70
Closeness
Sexual life 17/28 (61) 9/28 (32)* 13/27 (48) 12/24 (50) 57 53
Partner relation 24/29 (83) 23/29 (79) 25/28 (89) 24/29 (83) 82 80
Family life 25/27 (93) 25/29 (86) 27/28 (96) 26/28 (93) 84 84
Health
Somatic 15/29 (52) 14/29 (48) 18/28 (64) 22/29 (76) 75 74
Psychological 22/29 (76) 23/29 (79) 21/28 (75) 26/29 (90) 83 78
(P)ADL 25/29 (86) 26/29 (90) 26/28 (93) 28/29 (97) 92 96
Leisure
Leisure 19/29 (66) 23/29 (79) 19/28 (68) 18/29 (62) 62 59
Contacts 22/29 (76) 23/29 (79) 22/28 (79) 25/29 (86) 64 70
Provision
Vocation 19/27 (70) 20/29 (69) 15/26 (58) 19/26 (73) 61 58
Economy 20/29 (69) 21/29 (72) 18/28 (64) 22/29 (76) 50 48
*P = 0.039
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differed markedly from the comparators. Consid-
erably fewer patients were satisﬁed with their
somatic health. However, only satisfaction with
sexual life at 12 months’ follow-up showed signiﬁ-
cant differences between patients and compara-
tors, the former being signiﬁcantly less satisﬁed
(P = 0.039) (Table 3).
Couples with an active, partner-related sexual
life at follow-up reported coherence in high satis-
faction with life as a whole. Differences in satisfac-
tion with sexual life were found only in sexually
active couples where the patient reported a higher
satisfaction level than the partner prior to treat-
ment, but lower a year later. The sexually inactive
couples showed coherence in being unsatisﬁed
with their sexual life at baseline and after 12
months, with the exception of one couple.
Discussion
The major ﬁnding of this prospective investigation
was the high degree of coherence between patient
and partner experiences of sexuality as well as life
satisfaction before and after treatment of penile
carcinoma. Both patients and partners were satis-
ﬁed with life as whole at par with the general
population. This was true also for the domains
partner relationship, family life, leisure, social con-
tacts, psychological health, personal ADL, voca-
tion, and economy. Not surprisingly, patients’
somatic health was found to be lower than that of
the Swedish population. Furthermore, a year after
treatment, sexual satisfaction was signiﬁcantly
lower among patients. This ﬁnding contrasts to
our earlier retrospective study of 46 men with the
same diagnosis and treatment modalities, which
showed levels of satisfaction with sexual life equal
to those in the general male population [12]. This
difference could possibly be explained by a median
time of three years from treatment to assessment
in the retrospective study, indicating an adaptation
to the sexual situation after several years. In the
present prospective investigation, sexually inactive
couples were found to have low sexual satisfaction,
indicating the importance of acknowledging sexu-
ality in the case history as well as in the clinical
care of patients and partners.
We have not been able to locate earlier pub-
lished data on penile carcinoma and the effect on
couples’ sexual well-being, but there are, however,
ﬁndings in the literature suggesting that having a
partner with good sexual function positively affects
the sexual outcomes in males treated for prostate
cancer [19], and there is reason to believe that this
would be the case also for men with penile cancer.
Knowledge about how partners’ sexual dysfunc-
tions inﬂuence each other suggests the importance
of thinking in terms of partner relationship
when evaluating sexual outcomes after treatment
[20,21]. This is also supported by epidemiological
data showing that men’s sexual dysfunctions are
closely coherent with women’s dysfunctions and
vice versa [15,22].
Coping with the diagnosis of cancer, its treat-
ment and its recovery are dyadic processes within a
relationship. This dynamic process is affected by
both the patient’s and partners overall adjustment
to life as a whole and also to different life domains.
Generally, the onset of cancer have been found to
have a negative impact on both sexuality and sexual
relationships, most often seen as total cessation of
sexual activities or markedly decreased frequency
[23].
A fourth of the couples in the present sample
were without a mutual sexual life, and all of them
experienced low sexual satisfaction. Malignancy,
concomitant diseases, or lack of sexual interest were
reasons given for the sexual inactivity. In a popula-
tion with a median age of around 60 years, con-
comitant diseases, in patients as well as partners,
should be expected and kept in mind as belonging
to risk factors for sexual dysfunctions [24]. Occur-
rence of partners’ diagnosed comorbidity increased
between baseline and the 12-month follow-up.
This is in agreement with ﬁndings from a large
Swedish cohort study of partners to persons diag-
nosed with cancer; during the ﬁrst year after diag-
nosis, the partners were found to be vulnerable to ill
health [25]. Neither patients nor partners, in our
study, were found to be depressed. Anxiety, on the
other hand, was reported by 17% of the partners
before treatment but none a year later. Here,
patients showed a different pattern. One interpre-
tation is that the psychological defensemechanisms
differ in time for patient and partner. The HADS
has been used in patients with penile carcinoma; in
a study of 14 subjects, all with penile amputation,
D’Ancona et al. found none to be depressed or
experiencing anxiety [26]. However, in another
investigation of 17 patients with different treat-
ment regimes, 30% felt anxiety and 6% were
depressed [27].
The prevalence of sexual dysfunctions was gen-
erally high in the investigated men with penile
cancer compared with evidence-based epidemio-
logical data [24]. However, as discussed in a review
by Maddineni et al., prevalence studies of men
treated for penile carcinoma are rare, with small
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samples and without consensus in methods and
measurements [28]. Sexual outcomes have though
been studied after partial or total penectomy or
radiotherapy [6,7,29], and in recent decades, these
widened to several organ-preserving modalities
and glansectomy with subsequent reconstruction
[11,30,31]. In these studies, sexuality is not in focus
but described in one or two lines. For example,
Romero et al. only included patients that were
sexually active and without other serious illness
that could interfere with sexual function [7]. In a
study of patients receiving brachytherapy, Crook
et al. focused on erectile function at baseline and
follow-ups, showing that of 27 men who were
“potent” before treatment almost all retained their
erectile function afterwards [8].
Notably, in the present study, manifest
decreased sexual interest occurred more often than
expected for the patients, both at baseline (45%)
and a year after treatment (34%). Furthermore, a
high prevalence of dyspareunia, before treatment
(almost 50%), was somewhat surprising. However,
genital pain at baseline could be explained by
penile lesions, which is supported by the ﬁnding of
a much lower prevalence after treatment a year
later (12%). Decreased penile sensibility is another
ﬁnding which is clinically important when focus-
ing on sexuality and restoring sexual life and sat-
isfaction. Manifest retarded ejaculation occurred
more often in this group of patients than in the
general population. One main explanation of this
dysfunction, as well as of the increase in female
orgasmic dysfunction at follow-up, is psychologi-
cal rather than physical. Orgasm can be hindered
by worries, which are emotions that are present
when coping with cancer.
Manifest erectile dysfunction is the most often
investigated sexual dysfunction, both in descriptive
and analytical epidemiology. In the present study,
this dysfunction was not as pronounced as several
other dysfunctions, and furthermore, when occur-
ring, it was successfully treated with pharmaco-
logical treatment with PDE5 inhibitors. For the
female partner, low vaginal lubrication occurred
quite often which is expected due to the relatively
high age of the participants (i.e., postmenopausal).
This dysfunction can also be positively treated
with different pharmacological therapies such as
lubricants and hormonal therapy, which could
explain the decrease in prevalence at follow-up.
When diagnosed with penile carcinoma, not
only patients’ and partners’ sexual function but
also their experience of sexual satisfaction and the
importance of sexuality have to be considered as
indicators when deciding appropriate treatment
strategies. Sexual well-being among couples
dealing with cancer is not only a question of physi-
cal function; there is a possibility that the impact
of sexual problems negatively affects both the
patients’ and his partner’s self-conﬁdence and
thereby global life satisfaction [32,33]. Such an
impact will be an unnecessary burden during a
difﬁcult period in life and is an indication for a
broader approach to sexuality. Our ﬁndings con-
cerning the couples’ low levels of verbal commu-
nication on sexuality also highlight the need for
attention and the availability of sexological help
and perhaps treatment. This could preferably be
done as early as 6 months after diagnosis as we
found no signiﬁcant differences in answers at the
two occasions for the interviews.
The beneﬁt of organ-sparing techniques for
maintaining sexual function has illuminated the
need for studying sexual outcomes in penile carci-
noma. In the past decade, glansectomy, in combi-
nation with glans reconstruction, has been
evaluated as an alternative to partial penectomy,
but still with large differences in the use of vali-
dated tools and results of sexual outcomes
[11,30,31,34]. Nevertheless, when summarizing
these ﬁndings, and not surprisingly, there is more
to gain in sexual well-being for both patients and
partners when there is a possibility of penile-
preserving treatment. The partner perspective in
penile carcinoma has not, as far as we know, been
studied. In our earlier retrospective study, we
described the partner perspective from point of
view of the patients. This approach has also been
used by Gulino et al. who found that 6 months
after glans reconstruction, patients rated the rela-
tionships with partner and family as being as good
as before the debut of the disease [11].
The present study has its limitation in the small
number of patients and partners; thus, interpreta-
tions should be made with caution. However,
penile carcinoma is a rare malignancy, and a
strength of the study is that the participants belong
to a consecutive series of men younger than 75
years and were treated at one and the same uni-
versity hospital specializing in laser treatment of
penile carcinoma. The response rate at baseline
and at the 12-month follow-up was high (83% and
71%, respectively). Furthermore, an experienced
medical social worker performed all interviews.
Penile carcinoma is a rare malignancy sur-
rounded by deﬁcient knowledge in society and
with several treatment options available. Many
patients are unaware of the risk for negative side
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effects on sexual function and are not able to
process these questions before the diagnosis. The
importance of involving the partner in the consul-
tation process together with the patient, the
physician, and other medical professionals is
underlined.
Conclusion
There is a high level of within-couple agreement
between patients’ and partners’ experiences of
sexual activities, sexual function, and life satisfac-
tion before and 1 year after organ-sparring
treatment of penile carcinoma. The couples’ sat-
isfaction with life as a whole is on a par with that
of the general population. This is true also for
several domains of life. Not surprisingly, they
experienced lower satisfaction with health and
with sexual life 1 year after treatment. The latter
ﬁnding can be explained by a rather high propor-
tion being unsatisfactory sexually inactive, and
sexual dysfunctions were not uncommon. The
sexual verbal communication was low, indicting
difﬁculties in the coping process. Thus, sexologi-
cal case history, counseling, and/or treatment
seems to be important for this group of patients
and their spouses.
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